EYEMATE-SC试验中用于眼压遥测的脉络膜上腔传感器的安全性与性能
这项前瞻性、多中心、开放标签、单臂介入临床试验在24例接受非穿透性青光眼手术的开角型青光眼患者中同期植入EYEMATE-SC脉络膜上腔眼压传感器。6个月随访未发生装置移位、脱位或严重装置相关并发症,传感器与Goldmann压平眼压计测量的一致性随时间改善。
要点
- 24眼中15眼行小梁切开术、9眼行深巩膜切除术,均成功植入传感器。
- 无装置移位、脱位或严重装置相关并发症发生。
- 眼压差在±5 mmHg内的眼比例从第3天78%改善至6个月100%。
核心结论
- 6个月时EYEMATE-SC传感器安全且耐受良好,并允许连续眼压监测。
研究设计与样本
- 前瞻性、多中心、开放标签、单臂介入临床试验,纳入24例开角型青光眼患者的24眼,均常规计划行非穿透性青光眼手术(小梁切开术或深巩膜切除术)并同期植入EYEMATE-SC传感器,随访6个月评估安全性与性能。
主要发现
- 15眼行小梁切开术、9眼行深巩膜切除术,均成功植入传感器,未发生装置移位、脱位或严重装置相关并发症。
- 眼压一致性分析共纳入367次比较,Goldmann压平眼压计与EYEMATE-SC测量的总体平均差为1.31 mmHg(一致性界限下限7.55 mmHg,上限-4.92 mmHg)。
- 第10天最大差值为2.5 mmHg±3.96(一致性界限0.30-2.29),6个月后持续改善至一致性-0.15 mmHg±2.28(一致性界限-1.24至0.89)。
- 眼压差在±5 mmHg内的眼比例从第3天78%改善至6个月100%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To investigate the safety and performance of a telemetric suprachoroidal intraocular pressure (IOP) sensor (EYEMATE-SC) and the accuracy of its IOP measurements in open angle glaucoma (OAG) patients undergoing simultaneous non-penetrating glaucoma surgery (NPGS). METHODS: Prospective, multicentre, open-label, single-arm, interventional clinical trial. Twenty-four eyes of 24 patients with OAG regularly scheduled for NPGS (canaloplasty or deep sclerectomy) were simultaneously implanted with an EYEMATE-SC sensor. Six-month follow-up on the sensor's safety and performance as well as on the level of agreement between the EYEMATE-SC measurements and IOP measurements with Goldmann applanation tonometry (GAT). RESULTS: The eyes underwent canaloplasty (n=15) or deep sclerectomy (n=9) and achieved successful implantation of the sensor. No device migration, dislocation or serious device-related complications occurred. A total of 367 comparisons were included in the IOP agreement analysis. The overall mean difference between GAT and EYEMATE-SC measurements was 1.31 mm Hg (lower limit of agreement (LoA) 7.55 mm Hg; upper LoA -4.92 mm Hg). The maximum difference of 2.5 mm Hg ±3.96 (LoA 0.30-2.29) was reached on day 10 and continuously improved to an agreement of -0.15 mm Hg ±2.28 (LoA -1.24 to 0.89) after 6 months. Accordingly, the percentage of eyes within an IOP difference of ±5 mm Hg improved from 78% (day 3) to 100% (6 months). CONCLUSIONS: After 6 months, the EYEMATE-SC sensor was safe and well tolerated, and allowed continual IOP monitoring. TRIAL REGISTRATION NUMBER: NCT03756662.
引用
- Szurman P, Mansouri K, Dick HB, et al. Safety and performance of a suprachoroidal sensor for telemetric measurement of intraocular pressure in the EYEMATE-SC trial. Br J Ophthalmol. 2021. PMID: 34772665. doi:10.1136/bjophthalmol-2021-320023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。